Clinical Trials Directory

Trials / Completed

CompletedNCT03634748

Thrombolysis in stRoke With Unknown onSet Based on noncontrasT CT

Thrombolysis in stRoke With Unknown onSet Based on Non-contrasT CT (TRUST CT). An International, Multicenter, Registry-based Study

Status
Completed
Phase
Study type
Observational
Enrollment
117 (actual)
Sponsor
University Hospital Tuebingen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Multicentric, observational, registry-based study of 0.9 mg/kg i.v. thrombolysis in wake-up stroke or stroke with unknown onset based on non-contrast CT appearance only

Detailed description

Thrombolysis in wake-up stroke (WUS) or stroke with unknown onset (SUO) has been recently proven to be safe and effective using magnetic resonance imaging (MRI). However, in most of the thrombolyzing hospitals worldwide MR imaging is not available. We hypothesize that pragmatic non-contrast CT (NCCT)-based WUS/SUO thrombolysis may be feasible and safe. Methods: TRUST-CT is an international multicenter registry-based study. WUS/SUO patients undergoing NCCT-based thrombolysis with NIHSS ≥ 4 and initial ASPECTS ≥ 7 are included and compared to propensity score matched non-thrombolyzed WUS/SUO controls. Primary endpoint is symptomatic intracranial hemorrhage (ICH); secondary endpoints include 24-hour NIHSS change of ≥ 4 and modified Rankin Score (mRS) at 90 days.

Conditions

Timeline

Start date
2017-09-01
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2018-08-16
Last updated
2019-02-04

Locations

5 sites across 4 countries: Austria, Germany, Slovakia, Switzerland

Source: ClinicalTrials.gov record NCT03634748. Inclusion in this directory is not an endorsement.